生物活性人工血管体内降解及血管再生调控
批准号:
81401534
项目类别:
青年科学基金项目
资助金额:
23.0 万元
负责人:
王恺
依托单位:
学科分类:
组织器官再生机制与调控
结题年份:
2017
批准年份:
2014
项目状态:
已结题
项目参与者:
王志红、朱美峰、王家宁、周鑫、潘伊娃
中文摘要
静电纺丝制备的PCL血管材料具有良好的生物相容性,但其较小的纤维孔径和较慢的降解速度易导致植入后期发生平滑肌钙化。血管神经能够有效维持平滑肌的正常生理功能、防止其发生病理增生与钙化,但单纯电纺PCL材料没有生物活性,不能有效促进血管神经纤维重建。基于上述问题,我们在血管材料孔结构设计的基础上,对其进行活性修饰和降解调控,以达到改善和促进血管再生的目的。在活性修饰方面,我们拟通过混纺PCL与负载生物活性因子的丝素蛋白纳米颗粒,使内层缓释VEGF,加速内皮化;中层缓释PDGF-BB,同时配以大孔和纤维取向结构,促进和诱导平滑肌取向再生;外层缓释Netrin-1,促进血管神经纤维重建。在材料降解方面,基于γ射线对PCL分子链的断链与交联作用,我们在安全剂量范围内通过γ射线调控材料体内降解,使之与血管再生速度相匹配。通过兔颈动脉血管移植研究血管材料的生物活性与降解对血管再生的调控作用。
英文摘要
Electrospun PCL vascular graft was well known for its good biocompatibility, but one of its drawbacks is that the inherently small pore size and slow degradation rate would most likely lead to calcification in the late phase of implantation. Nerve fibers, which can effectively maintain the physiological function of vascular smooth muscle and inhibit pathological smooth muscle cell proliferation and calcification, play an important role in blood vessel regeneration. While electrospun PCL vascular graft can't effectively promote reconstruction of nerve fibers, because it has no bioactivity. Based on the issue above, our study mainly focus on the bioactivity modification and degradation manipulation for vascular grafts with the structure desigin. Regarding the bioactivity modification,the inner layer was prepared through co-electrospinning PCL and silk fibroin nanoparticles A loaded with VEGF to accelerate endothelialization;the middle layer was modified to guide oriented regeneration of smooth muscle cells via co-electrospinning PCL and silk fibroin nanoparticles B loaded with PDGF-BB, electrospraying PEO microparticles were utilized to increase porosity of the middle layer, and an high-speed rotation collector was use to align the nanofiber;the outer layer was prepared via electrospinning PLGA and co-electrospinning PCL and silk fibroin nanoparticles C loaded with Netrin-1 to improve nerve fibers growth,which can inhinbit pathological smooth muscle cell proliferation and calcification and also provide mechanical support at the same time. Furthermore, given the fact that γ radiation can induce PCL main chain scission reactions and crosslinking, we used it to adjust the degradation rate of PCL so that it matches the speed of tissue regeneration. The effect of the bioactivity and degeration of the vascular grafts for vascular regeneration was investigated through rabbit carotid artery implantation.
临床对于小口径人工血管(< 6 mm)需求巨大,但是尚无理想的产品可以使用,因此,需要研发性能优良的小口径人工血管以满足临床需求。本项目着重对小口径血管材料的孔结构设计、功能修饰和降解性三个方面加以研究,以期为构建理想的小口径人工血管材料奠定基础。在结构设计方面,我们以电喷聚乙二醇(PEO)微球作为致孔剂,制备了中层致孔的三层结构的静电纺丝聚己内酯(PCL)血管材料,植入兔颈动脉后,大量的巨噬细胞快速地迁移进了致孔层,释放了单核细胞趋化因子-1(MCP-1)和血管内皮细胞生长因子(VEGF),有效地促进了血管内皮和平滑肌的再生。在功能修饰方面,我们利用基因融合技术构建了融合蛋白VEGF-HGFI,该蛋白能够在电纺PCL材料表面通过疏水的相互作用形成VEGF蛋白涂层,该涂层改善了PCL血管材料的亲水性和血液相容性,植入大鼠腹主动脉后能够显著促进支架材料的内皮化和组织再生;在降解调控方面,我们通过对纺技术将PCL与可快速降解的(聚对二氧环己酮)PDO复合,制备了PCL/PDO复合纤维血管材料,体内、外降解实验证实PDO纤维的复合加速了支架材料的降解速度,该复合材料植入大鼠腹主动脉后,显示了良好的通畅性,PDO纤维的降解没有引起动脉瘤的发生,但PDO纤维降解产生了额外的空间促进了平滑肌细胞在血管壁中的再生。本项目所取得的研究成果为新一代小口径人工血管的构建提供了重要的参考价值。
期刊论文列表
专著列表
科研奖励列表
会议论文列表
专利列表
登录
查看更多内容
Small-diameter hybrid vascular grafts composed of polycaprolactone and polydioxanone fibers.
由聚己内酯和聚二氧环己酮纤维组成的小直径混合血管移植物
DOI:
10.1038/s41598-017-03851-1
发表时间:
2017-06-15
期刊:
Scientific reports
影响因子:
4.6
作者:
[Pan Y, Zhou X, Wei Y, Zhang Q, Wang T, Zhu M, Li W, Huang R, Liu R, Chen J, Fan G, Wang K, Kong D, Zhao Q]
通讯作者:
Zhao Q
Noncovalent Bonding of RGD and YIGSR to an Electrospun Poly(epsilon-Caprolactone) Conduit through Peptide Self-Assembly to Synergistically Promote Sciatic Nerve Regeneration in Rats
RGD 和 YIGSR 通过肽自组装非共价键合到静电纺聚(ε-己内酯)导管上,协同促进大鼠坐骨神经再生
DOI:
10.1002/adhm.201600860
发表时间:
2017
期刊:
Advanced Healthcare Materials
影响因子:
10
作者:
[Zhu Lei, Wang Kai, Ma Teng, Huang Liangliang, Xia Bing, Zhu Shu, Yang Yafeng, Liu Zhongyang, Quan Xin, Luo Kai, Kong Deling, Huang Jinghui, Luo Zhuojing]
通讯作者:
Luo Zhuojing
Functional Modification of Fibrous PCL Scaffolds with Fusion Protein VEGF-HGFI Enhanced Cellularization and Vascularization
用融合蛋白 VEGF-HGFI 增强细胞化和血管化对纤维 PCL 支架进行功能修饰
DOI:
10.1002/adhm.201600226
发表时间:
2016
期刊:
Advanced Healthcare Materials
影响因子:
10
作者:
[Zhao Liqiang, Ma Shaoyang, Pan Yiwa, Zhang Qiuying, Wang Kai, Song Dongmin, Wang Xiangxiang, Feng Guowei, Liu Ruming, Xu Haijin, Zhang Jun, Qiao Mingqiang, Kong Deling]
通讯作者:
Kong Deling
Effect of Resveratrol on Modulation of Endothelial Cells and Macrophages for Rapid Vascular Regeneration from Electrospun Poly(epsilon-caprolactone) Scaffolds
白藜芦醇对电纺聚(ε-己内酯)支架内皮细胞和巨噬细胞快速血管再生的调节作用。
DOI:
10.1021/acsami.6b16573
发表时间:
2017
期刊:
Acs Applied Materials & Interfaces
影响因子:
9.5
作者:
[Wang Zhihong, Wu Yifan, Wang Jianing, Zhang Chuangnian, Yan Hongyu, Zhu Meifeng, Wang Kai, Li Chen, Xu Qingbo, Kong Deling]
通讯作者:
Kong Deling
Enhanced vascularization in hybrid PCL/gelatin fibrous scaffolds with sustained release of VEGF.
混合 PCL/明胶纤维支架增强血管化并持续释放 VEGF
DOI:
10.1155/2015/865076
发表时间:
2015
期刊:
BioMed research international
影响因子:
--
作者:
[Wang K, Chen X, Pan Y, Cui Y, Zhou X, Kong D, Zhao Q]
通讯作者:
Zhao Q
共 7 条
低氧模拟反应调控小口径人工血管再生的作用及细胞来源研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:55万元
-
批准年份:2021
-
负责人:王恺
-
依托单位:
仿生电信号血管材料调控血管组织再生与功能稳态的作用研究
-
批准号:91939112
-
项目类别:重大研究计划
-
资助金额:40.0万元
-
批准年份:2019
-
负责人:王恺
-
依托单位:
聚合物熔融纺丝纤维与脱细胞基质构成的杂化人工血管材料的构建与功能修饰研究
-
批准号:81772000
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2017
-
负责人:王恺
-
依托单位:
面向敏感网络图像过滤的原生数字图像文本提取关键技术研究
-
批准号:61201424
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2012
-
负责人:王恺
-
依托单位:
国内基金
海外基金